Tango Therapeutics Inc.

TNGX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$21.76-4.23%

2026-11-02

Financials

Valuation Metrics

Tango Therapeutics Inc.'s Market Cap is $3.15B. At end of 2025 it was $1.03B. Ranked #1632 of 3,118 in US market (top 52%), #574 of 1,474 on NASDAQ (top 39%), #95 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 36%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$3.15B	US#1,632/3,118 Sec#95/265
Revenue	$54M	US#2,735/3,118 Sec#144/265
Net Income	$-124M	US—/3,118 Sec—/265
Total Assets	$1.07B	US#2,440/3,118 Sec#100/265
Net Assets	$1.02B	US#1,741/3,118 Sec#63/265
Value
P/B	3.07x	US#1,848/3,118 Sec#102/265
P/S	58.49x	US#2,929/3,118 Sec#173/265
FCF Yield	-4.58%	US—/3,118 Sec—/265
Profitability
ROE	-12.08%	US#2,390/3,118 Sec#86/265
ROA	-11.52%	US#2,680/3,118 Sec#105/265
Op. Margin	-253.38%	US#2,753/3,118 Sec#140/265
Revenue Growth	121.47%	US#76/3,118 Sec#28/265
Financial Health
Debt Ratio	4.82%	US#36/3,118 Sec#12/265
Total Debt	$32M	US#2,673/3,118 Sec#172/265
FCF	$-144M	US#2,708/3,118 Sec#177/265
Cash	$346M	US#1,316/3,118 Sec#74/265
Current Ratio	50.82x	US#55/3,118 Sec#5/265
Performance
1Y Return	168.31%	US#40/3,118 Sec#15/265
1M Return	-6.37%	US#2,406/3,118 Sec#176/265
From 52W High	-36.73%	US#2,116/3,118 Sec#142/265
1Y MDD	-33.89%	US#1,575/3,118 Sec#83/265
Trading
Volume	3,272,163 shares	US#429/3,118 Sec#29/265
Trading Value	$73M	US#849/3,118 Sec#43/265
Per Share
EPS	$-0.86	US—/3,118 Sec—/265
BPS	$7.08	US#2,076/3,118 Sec#97/265